Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.
Scandinavian Journal of Gastroenterology|January 6, 2018
Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre StudyLina Lindström, Kristin K Jørgensen, Kirsten M Boberg, et al.
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
Carcinogenesis|May 16, 2009
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinomaMonika Forsbring, Erik S Vik, Bjørn Dalhus, et al.
Journal of Crohn'S & Colitis|November 19, 2013
Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?M Block, K K Jørgensen, T Oresland, et al.
Clinical and Translational Gastroenterology|March 1, 2021
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing CholangitisLars Bossen, Mette Vesterhus, Johannes R Hov, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 5, 2015
Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complicationsTrygve Thorsen, Ulrika S Dahlgren, Einar Martin Aandahl, et al.
Scientific Reports|June 13, 2019
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitisAmandeep K Dhillon, Andreas E Kremer, Martin Kummen, et al.
Scandinavian Journal of Gastroenterology|August 10, 2001
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitisK M Boberg, A Spurkland, G Rocca, et al.
Pageof 12